PRC Clinical Selects SimpleCTMS Clinical Trial Management System
Trial By Fire Solutions, an eClinical solution provider specializing in clinical study management applications, announced that
Through this strategic collaboration, PRC Clinical will incorporate SimpleCTMS into their suite of eClinical services. The addition of SimpleCTMS compliments their existing provider relationships to rapidly execute a full suite of clinical services while maintaining their high level of quality standards.
"SimpleCTMS is a very robust and intuitive system with real-time information at our fingertips, comprehensive reports and amazing customer support," said Curtis Head, PRC Clinical's President. "The PRC Clinical team is delighted to add this powerful tool to all of our studies to increase our trial management effeciency and value to sponsors."
"Having worked along side the PRC Clinical team for many years, we are delighted they chose SimpleCTMS. With their strong reputation as a CRO, they are a highly complementary addition to our diverse client base. PRC Clinical recognized the immediate benefits they could gain from SimpleCTMS, as well as the ability to mold the system to fit their growing client base and wide variety of clinical studies," said Nancy Cecchettini, Co-founder and Chief Product Officer at Trial By Fire Solutions.
In addition to using SimpleCTMS for core study management tasks, the CTMS will provide compelling performance visualizations and data transparency to PRC Clinical's prospective and existing client base. SimpleCTMS will easily integrate with existing eClinical systems to leverage external data and centralize tracking of key study metrics.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025